23 05, 2018 Sabrina Arena et. al, Characterization of tumor-derived mesenchymal stem cells potentially differentiating into cancer-associated fibroblasts in lung cancer Diatech Pharmacogenetics2018-05-23T15:21:55+02:00 Read More
6 04, 2018 Valeria Maffeis et. al, Onycholemmal carcinoma: A case report with its molecular profiling Diatech Pharmacogenetics2018-04-12T15:41:02+02:00 Read More
31 01, 2018 Fabrizio Tabbò et. al, Cell of origin markers identify different prognostic subgroups of lung adenocarcinoma Diatech Pharmacogenetics2018-03-08T13:51:25+01:00 Read More
15 01, 2018 Veronique Tack et al., RAS testing for colorectal cancer patients is reliable in European laboratories that pass external quality assessment Diatech Pharmacogenetics2018-02-01T13:02:13+01:00 Read More
9 01, 2018 Maria Rosaria Raspollini et al., Intratumoural heterogeneity may hinder precision medicine strategies in patients with clear cell renal cell carcinoma Diatech Pharmacogenetics2018-02-01T12:32:07+01:00 Read More
9 01, 2018 M. Rosaria Raspollini et.al, Intratumoural heterogeneity may hinder precision medicine strategies in patients with clear cell renal cell carcinoma Diatech Pharmacogenetics2018-01-09T11:14:45+01:00 Read More
7 12, 2017 Chiara Pesenti et. al, MassARRAY-based simultaneous detection of hotspot somatic mutations and recurrent fusion genes in papillary thyroid carcinoma: the PTC-MA assay Diatech Pharmacogenetics2017-12-07T11:43:46+01:00 Read More
21 11, 2017 Giovanna De Meglio et al., A32 How can molecular heterogeneity impact on treatment choice in advanced colorectal cancer? Diatech Pharmacogenetics2018-01-30T10:41:04+01:00 Read More
21 11, 2017 Roberta Minari et. al, Primary resistance to osimertinib due to SCLC transformation: Issue of T790M determination on liquid re-biopsy Diatech Pharmacogenetics2018-01-30T10:43:35+01:00 Read More
6 11, 2017 Emanuela Romagnoli et. al, A25 Management of folinic acid administration in patients with metastatic colo-rectal cancer Diatech Pharmacogenetics2018-01-30T10:46:45+01:00 Read More
